Taking people in NetherlandsPhase 1
Testing a fluorescence endoscopy method for rectal cancer
Tests a fluorescence endoscope scan to measure PD-1 and PD-L1 in adults with rectal cancer.
Plain-language title generated from the registry record
Registry title: Evaluating PD-1/PD-L1 in rectal cancer by quantitative fluorescence molecular endoscopy.
Key facts
- Where
- Groningen, NetherlandsSee the site
- Phase
- Phase 1
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with rectal cancer. It studies PD-1/PD-L1 using quantitative fluorescence molecular endoscopy.
- Age
- 18 years and older
- Sex
- All sexes can join.
Read by machine on 9 November 2026.
Where in Netherlands
- Universitair Medisch Centrum GroningenGroningen, NetherlandsTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Universitair Medisch Centrum Groningen
- Trial code
- NCT06304597EU 2023-507106-13-00
- Record updated
- 27 August 2026